Etretinate (Tegison®) is a medication used to treat severe psoriasis. It was removed from the US market in 1988 and the Canadian market in 1996.

Administration

Precautions

• Eteretinate is a teratogen, and may cause birth defects long after use. Therefore, etretinate should only be used if one is never to get pregnant.
• Etretinate should be avoided in children, as it may interfere with growth of bone.

Side effects

• Hepatitis
• Pseudotumor cerebri